Chronic News and Research

RSS

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

9 Jan 2010

Genentech's ACTEMRA approved to treat RA

Genentech, Inc., a wholly owned member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.

8 Jan 2010

A holistic approach to weight loss

When your New Year's resolution to lose weight crumbles as fast as the cookie touching your lips, it's time to admit that diets don't work. More successful is a holistic approach to losing weight that lets you feel good about feeding your body the nourishment it craves.

8 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

3Sbio submits registrational clinical trial application for Feraheme injection

3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.

8 Jan 2010

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.

8 Jan 2010

Researchers identify key epigenetic mechanism that helps explain cocaine's addictiveness

Researchers have identified a key epigenetic mechanism in the brain that helps explain cocaine's addictiveness, according to research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

8 Jan 2010

Study reveals members who had mental health diagnosis show improved outcomes

A recent study by Aetna Disability and Absence management of disability members who also had a mental health diagnosis showed that members spent an average of seven fewer days on disability when compared to an industry benchmark.

8 Jan 2010

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients

Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

8 Jan 2010

Congress approves $1.5 million for first-ever psoriasis patient registry at CDC

Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC).

8 Jan 2010

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata’s lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

Abnormally high or low blood calcium levels are linked to an increased chance of premature death in non-dialysis kidney disease patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

7 Jan 2010

IHPM and i.e. join to form MAGNETT Health to improve employees' health

The Institute for Health and Productivity Management (IHPM) and i.e., LLC have joined to form MAGNETT Health, LLC using innovative engagement techniques and mobile health messaging technologies to inspire employees in improving and maintaining their health with achievable, lasting behavior change.

7 Jan 2010

BioTrends Research Group’s syndicated reports provide comprehensive insight on renal anemia market

BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. The reports are based on responses to online surveys completed by over 300 Nephrologists in the US, over 200 Nephrologists in Europe (UK, France, Germany, Italy and Spain) and 40 Nephrologists in Canada during November / December 2009.

7 Jan 2010

MSHA selects Allscripts EHR and PM solutions to enhance patient care

Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

7 Jan 2010

Diabetes patients with Part D coverage gap are less likely to stick to their medications

Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.

7 Jan 2010

Drug companies still under great and growing pressure to bring more products to market

Although drug developers are improving R&D efficiency, in part by terminating more unpromising drugs earlier in development, their continued success will depend on how well they partner with other firms at specific points on the development spectrum, according to the Tufts Center for the Study of Drug Development.

7 Jan 2010

The Methodist Hospital offers web-based tool to help patients understand their health care better

The interactive program from Emmi Solutions describes and illustrates upcoming procedures for patients to help educate them on procedures such as cardiac bypass or knee replacement. It also helps patients understand how to manage chronic conditions like diabetes or heart failure.

7 Jan 2010

Nonin Medical to demonstrate Onyx II fingertip pulse oximeter

Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.

7 Jan 2010

Chronic News and Research

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Genentech's ACTEMRA approved to treat RA

A holistic approach to weight loss

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

3Sbio submits registrational clinical trial application for Feraheme injection

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Researchers identify key epigenetic mechanism that helps explain cocaine's addictiveness

Study reveals members who had mental health diagnosis show improved outcomes

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients

Congress approves $1.5 million for first-ever psoriasis patient registry at CDC

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

IHPM and i.e. join to form MAGNETT Health to improve employees' health

BioTrends Research Group’s syndicated reports provide comprehensive insight on renal anemia market

MSHA selects Allscripts EHR and PM solutions to enhance patient care

Diabetes patients with Part D coverage gap are less likely to stick to their medications

Drug companies still under great and growing pressure to bring more products to market

The Methodist Hospital offers web-based tool to help patients understand their health care better

Nonin Medical to demonstrate Onyx II fingertip pulse oximeter

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News